"What else do you have to do that will actually have to affect the Iranians' calculus?" said Amos Hochstein, who served as U.S. special envoy for international energy affairs...World Politicsread more
Reports of tensions may have been sparked by Kraft Heinz's underperformance, and because of accounting problems at the packaged goods company.Investingread more
The leaders of Japan and China got off to a tense start but have made significant progress in turning around their relations in recent years.Asia Politicsread more
Tech's hottest IPOs of the year, including Beyond Meat and Zoom, dropped on Monday, falling more than the broader market.Technologyread more
Citi Private Bank says it has maintained an "overweight" stance on stocks in China, Hong Kong, Taiwan and South Korea.Asia Marketsread more
FedEx sued the U.S. government, saying it should not be held liable if it inadvertently shipped products that violated a Trump administration ban on exports to some Chinese...Traderead more
SpaceX used its high speed boat called "Ms. Tree" to catch the nosecone its Falcon 9 rocket after Monday's launch.Investing in Spaceread more
Stocks in Asia slipped on Tuesday, while investors looked toward a meeting between U.S. President Donald Trump and Chinese President Xi Jinping set to happen later in the...Asia Marketsread more
A week of dovish fireworks out of the central banking community has just gone by with most of the world's leading central banks now guiding towards easing in light of downside...Commentaryread more
"We do not seek conflict with Iran or any other country," Trump tells reporters in the Oval Office.Politicsread more
Chinese Vice Premier Liu He held a phone conversation with U.S. Trade Representative Robert Lighthizer and U.S. Treasury Secretary Steven Mnuchin, China's Ministry of Commerce...World Economyread more
Even Martin Shkreli doesn't want anything to do with Martin Shkreli.
A man with the same name as the notorious "pharma bro" Shkreli was arraigned in the same courthouse, in the same courtroom, with the exact same judge on different criminal charges as those facing Shkreli on Friday.
Reporters covering the fifth day of jury deliberations for the ongoing securities fraud trial of the ex-pharmaceuticals firm CEO Shkreli packed into the courtroom in Brooklyn, New York, federal court to watch the deja vu scene play out.
Adding to the oddness was the fact that the high-powered lawyer Benjamin Brafman, who represents 34-year-old Martin Shkreli in the securities fraud case, was representing one of eight co-defendants of the other, 59-year-old Martin Shkreli, during Friday's proceeding.
Both Shkrelis are of Albanian descent but are not related to one another.
During the proceeding Friday, Brafman's client Shkreli was not in the courtroom when his namesake was arraigned on money-laundering charges related to alleged drug trafficking by a gang that also is accused of trafficking in weapons from the nation of Kosovo.
"There's another Martin Shkreli in this case. How weird is that?" quipped one of the case's other lawyers to a journalist after the arraignment.
The other Shkreli grinned broadly over at reporters after Judge Kiyo Matsumoto called his name out in court. Matsumoto also smiled.
The other Shkreli also accepted a warm handshake from Pashko Shkreli, the father of the younger Martin Shkreli, who happened to be sitting in the courtroom gallery directly in front of him.
"I don't need that kind of fame," said the other Shkreli, who smiled wryly when a reporter asked what he thought of his "newfound fame" after his lawyer entered a not-guilty plea.
The criminal complaint against the other Shkreli pointedly says, in a terse footnote, that, "This is not the same Martin Shkreli who is currently on trial in the Eastern District of New York."
The other Shkreli, who lives in Westchester County, New York, didn't respond when the reporter asked if he would start an account on Twitter, the social-media messaging site that the pharmaceutical executive Shkreli had been repeatedly banned from. That Shkreli was tweeting Friday from elsewhere in the courthouse, commenting on the appearance of several female reporters.
When CNBC asked him when he first became aware of the younger Shkreli, who gained widespread notoriety in 2015 for hiking the price of a drug by 5,000 percent, the older Shkreli likewise declined to answer, smiling as he shook his head.
At that point, Shkreli's lawyer, Brian Waller, stepped in and said he didn't want his client speaking with reporters. The younger Shkreli's lawyers likewise have asked him repeatedly not to talk to the media, given his habit of making outrageous comments.
The courtroom soon emptied out, leaving behind the legal team of Martin Shkreli, the "pharma bro" one, to resume their patient wait for a verdict in the case.